Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Stellate Ganglion Block on ME/CFS Symptoms and Metabolites

NCT05664711 is registered in ClinicalTrials.gov with Neuroversion, Inc. as lead sponsor.

NCT NCT05664711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05664711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Stellate Ganglion Block on ME/CFS Symptoms and Metabolites
Lead sponsor
Neuroversion, Inc.
Phase
Phase 1
Overall status
Completed
Start date
March 15, 2023
Completion date
January 15, 2024
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic fatigue and immune dysfunction syndrome, chronic fatigue disorder, chronic fatigue syndrome, chronic fatigue-fibromyalgia syndrome, encephalomyelitis, myalgic, infectious mononucleosis-like syndrome, chronic, myalgic encephalomyelitis, postviral fatigue syndrome, systemic exertion intolerance disease